CIK 0001232524 · Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- EIN
- 981032470
- Phone
- 353-1-634-7800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,420,682
- in 10 filings, $24.9M under 10b5-1 plans
Net −$41,420,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- COZADD BRUCE C −$20.4M Director sold 20% of stake
- Iannone Robert −$19.2M EVP, Global Head of R&D & CMO sold 54% of stake
- GALA RENEE D −$1.2M President & CEO sold 3% of stake
- Carr Patricia −$327K SVP, Chief Accounting Officer sold 18% of stake
- Patil Neena M −$289K EVP & Chief Legal Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-05 | GALA RENEE D President & COO | Shares withheld for taxes | −1,736 | $115.21 | $200K | 55,357 |
| 2024-03-07 | Carr Patricia SVP, Chief Accounting Officer | Sale | −1,768 | $116.98 | $207K | 6,596 |
| 2024-03-06 | Carr Patricia SVP, Chief Accounting Officer | Sale | −1,236 | $120.85 | $149K | 9,064 |
| 2024-03-06 | Carr Patricia SVP, Chief Accounting Officer | Sale | −700 | $117.51 | $82K | 8,364 |
| 2024-03-05 | GALA RENEE D President & COO | Shares withheld for taxes | −3,622 | $117.53 | $426K | 57,093 |
| 2024-03-05 | Pearce Samantha SVP, Head of Europe & Internat | Shares withheld for taxes | −2,474 | $117.53 | $291K | 16,922 |
| 2024-03-05 | Patil Neena M EVP & Chief Legal Officer | Shares withheld for taxes | −3,432 | $117.53 | $403K | 41,629 |
| 2024-03-05 | Iannone Robert EVP, Global Head of R&D | Shares withheld for taxes | −4,294 | $117.53 | $505K | 62,226 |
| 2024-03-05 | COZADD BRUCE C Chairman & CEO | Shares withheld for taxes | −22,436 | $117.53 | $2.6M | 429,809 |
| 2024-03-01 | Henderson Mary Elizabeth SVP, Technical Operations | Grant or award | +5,178 | 15,941 | ||
| 2024-03-01 | Carr Patricia SVP, Chief Accounting Officer | Grant or award | +2,987 | 10,300 | ||
| 2024-03-01 | Pearce Samantha SVP, Head of Europe & Internat | Grant or award | +5,065 | 19,396 | ||
| 2024-03-01 | Patil Neena M EVP & Chief Legal Officer | Grant or award | +12,348 | 45,061 | ||
| 2024-03-01 | Iannone Robert EVP, Global Head of R&D | Grant or award | +16,928 | 66,520 | ||
| 2024-03-01 | GALA RENEE D President & COO | Grant or award | +19,916 | 60,715 | ||
| 2024-03-01 | COZADD BRUCE C Chairman & CEO | Grant or award | +50,187 | 452,245 | ||
| 2024-03-01 | Kennedy Patrick Director | Grant or award | +1,423 | 1,423 | ||
| 2024-03-01 | Johnson Philip L EVP & Chief Financial Officer | Grant or award | +15,932 | 15,932 | ||
| 2024-03-01 | Johnson Philip L EVP & Chief Financial Officer | Purchase | +12,000 | $119.65 | $1.4M | 27,932 |
| 2024-01-17 | Pearce Samantha SVP, Head of Europe & Internat | Grant or award | +2,210 | 15,369 |
Page 16 of 31 · 614 trades